1 / 14

Partner with Industry to Achieve NIAID’s Mission

Partner with NIAID's TTIPO for material exchanges, collaborative research, and licensing opportunities. Explore available resources and licensing options. Contact us for more information.

jaredn
Download Presentation

Partner with Industry to Achieve NIAID’s Mission

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Partner with Industry to Achieve NIAID’s Mission Haiqing Li, M.D., Ph.D. Senior Technology Transfer and Patent Specialist Technology Transfer and Intellectual Property Office (TTIPO) lihai@mail.nih.govMarch 21, 2019

  2. Partner with NIAID through TTIPO • Exchange Material & Information • Material Transfer Agreement (MTA) • Confidential Disclosure Agreement (CDA) • Non-Clinical Evaluation Agreement (NCEA) • and others For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

  3. NIAID Research Resource • https://www.niaid.nih.gov/research/resources • Filter Search Results by: • Disease or Condition • Discipline or Approach • Research Stage • Resource Type • NIAID Division For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

  4. Partner with NIAID through TTIPO • Collaborative Research • Research collaboration agreement (RCA) • Clinical trial agreement (CTA) • Collaborative research and development agreement (CRADA) • and others For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

  5. CRADA Subject Invention Cytonix Corporation Real time PCR technology used for sensitive, specific detection and quantification of nucleic acid targets For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

  6. Partner with NIAID or CDC through TTIPO • License • Research material, patented technology, software • Internal use, evaluation, commercialization • and others For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

  7. Vaccines SmithKline Beecham Vaccine against Hepatitis A Serum Institute of India Heat stable rotavirus vaccine, protecting against five most common rotavirus serotypes For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

  8. Therapeutics & Diagnostics MedImmune Immunoprophylaxis to reduce respiratory syncytial virus (RSV) related hospitalizations in high-risk infants and children PATH Biplex test for combined surveillance of Onchocerciasis (river blindness) and Lymphatic filariasis (elephantiasis) For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

  9. Veterinary Products Merial Limited Vaccine for dogs against distemper, parvovirus, hepatitis, respiratory disease and parainfluenza virus VCA Antech Diagnostic test for Lyme disease, heartworm, ehrlichiosis, and anaplasmosis in dogs For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

  10. From CDC Becton, Dickinson, and Company (BD) Protecting healthcare workers by detecting contamination from hazardous antineoplastic drugs BD HD Check System AP&G Co., Inc. A low cost mosquito trap that requires neither power nor pesticide Catchmaster Mosquito Trap For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

  11. Licensing Opportunities E-101-2013 A transferrable Norwalk virus epitope and detector monoclonal antibody Potential Application: Diagnostics and vaccine for Norovirus E-171-2013 Methods to regulate biofilm development Potential Application: Prevent infection on indwelling or implantable medical devices E-449-2013 Small molecule imaging of fungi by positron emission tomography scanning Potential Application: Diagnostics of Aspergillosis and other filamentous fungal infections For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

  12. Licensing Opportunities E-064-2015 A new class of immunomodulatory drugs for multiple sclerosis Potential Application: Therapeutics for multiple sclerosis E-260-2014 (hMPV) and E-215-2016 (hPIV) Fusion (F) proteins stabilized in prefusion conformation Potential Application: Vaccines for Human Metapneumovirus (hMPV) or Human Parainfluenza Virus (hPIV) E-234-2016 Coronavirus (CoV) spike (S) proteins stabilized in prefusion conformation Potential Application: Subunit vaccine platform for CoV including MERS and SARS For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

  13. Licensing Opportunities E-156-2017 Real-time PCR assay for detection of carbapenem antibiotic resistance genes of the IMP-type Potential Application: Detection of IMP genes in healthcare settings, antibiotic resistance surveillance E-009-2018 Encapsulated streptococcus compositions and methods Potential Application: Pneumococcal vaccine, probiotic, and diagnostic assay development For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

  14. Interested in NIAID and CDC Inventions? NIH OTT Licensing: https://www.ott.nih.gov/opportunities Federal Register Notices: https://www.federalregister.gov Biopharma Dealmakers: https://biopharmadealmakers.nature.com/users/15957-niaid-technology-transfer-and-intellectual-property-office For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

More Related